Zobrazeno 1 - 10
of 9 690
pro vyhledávání: '"aromatase inhibitor"'
Autor:
Huanyao Gao, Lixuan Wei, Shreya Indulkar, Thanh Thanh. L. Nguyen, Duan Liu, Ming-Fen Ho, Cheng Zhang, Hu Li, Richard M. Weinshilboum, James N. Ingle, Liewei Wang
Publikováno v:
Breast Cancer Research, Vol 26, Iss 1, Pp 1-14 (2024)
Abstract Background Endocrine therapy is the most important treatment modality of breast cancer patients whose tumors express the estrogen receptor α (ERα). The androgen receptor (AR) is also expressed in the vast majority (80–90%) of ERα-positi
Externí odkaz:
https://doaj.org/article/0906792d3b1b42248df6ef4f3c484ff2
Autor:
Peter A. Lee
Publikováno v:
JCRPE, Vol 16, Iss 2, Pp 235-242 (2024)
A rarely reported phenomenon of rapid-tempo puberty in which the physical changes of puberty and testosterone levels increase very rapidly has not been reported outside apart from in two reviews. The resulting rapid advancement of skeletal age causes
Externí odkaz:
https://doaj.org/article/756267fc523d422aaadc3d32da4f435a
Autor:
Roshanak Hariri, Maryam Baeeri, Negar Mohammadhosseini, Saeed Emami, Alireza Foroumadi, Maliheh Barazandeh Tehrani
Publikováno v:
Journal of Mazandaran University of Medical Sciences, Vol 33, Iss 227, Pp 13-23 (2023)
Background and purpose: The spread of cancer, coupled with the challenges posed by complex treatments, stands as one of the foremost medical issues in today's world. Researchers consistently strive to identify novel compounds with enhanced efficacy a
Externí odkaz:
https://doaj.org/article/91268b01d50240b3896bf7871671a769
Publikováno v:
Middle East Fertility Society Journal, Vol 28, Iss 1, Pp 1-8 (2023)
Abstract Background To evaluate the effect of adding letrozole to the antagonist ovarian stimulation protocol (COS) on in-vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) outcome in endometriosis patients. Methods This randomized clini
Externí odkaz:
https://doaj.org/article/c569ef9e9ff94818850aac668fb72551
Publikováno v:
Наукові горизонти, Vol 26, Iss 10, Pp 51-58 (2023)
Alimentary infertility is becoming increasingly important due to the toxic effects of mycotoxins, especially zearalenone and deoxynivalenol, which leads to a decrease in the efficiency of the cattle breeding industry, so it is necessary to examine th
Externí odkaz:
https://doaj.org/article/ef92157ae9bd4c4bab4f0fbcc766c776
Publikováno v:
Guoji Yanke Zazhi, Vol 23, Iss 10, Pp 1741-1744 (2023)
AIM: To analyze the effects of aromatase inhibitors(AIs)on the ocular surface microenvironment of the users.METHODS: A cross-sectional observational study was conducted. The study included postmenopausal women who received AIs treatment at galactopho
Externí odkaz:
https://doaj.org/article/64afe43b8a4f4464904da403f776b8f3
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 15, p 8455 (2024)
Anti-estrogenic therapy is established in the management of estrogen receptor (ER)-positive breast cancer. However, to overcome resistance and improve therapeutic outcome, novel strategies are needed such as targeting widely recognized aberrant epige
Externí odkaz:
https://doaj.org/article/ec7f0e1cf5d34145a8b07bdb605b1279
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Aromatase inhibitors (AIs) are a cornerstone adjuvant treatment of many hormone receptor-positive breast cancers, and nearly half of women taking aromatase inhibitors suffer from AI-induced arthralgia (AIA), also known as AI-associated musculoskeleta
Externí odkaz:
https://doaj.org/article/e1dbfdd7c04d43d89884f77b9f50b517
Autor:
Yee-Ming M Cheung, Rudolf Hoermann, Karen Van, Damian Wu, Jenny Healy, Bella Halim, Manjri Raval, Maria McGill, Ali Al-Fiadh, Michael Chao, Shane White, Belinda Yeo, Jeffrey D Zajac, Mathis Grossmann
Publikováno v:
Endocrine Connections, Vol 12, Iss 10, Pp 1-14 (2023)
Purpose: We previously demonstrated that 12 months of aromatase inhibitor (AI) treatment was not associated with a difference in body compositi on or other markers of cardiometabolic health when compared to controls. Here we report on the pre-planned
Externí odkaz:
https://doaj.org/article/d7c1404461cf45eea291656d8fa7070b
Autor:
Alberto Alvarado-Miranda, Fernando Ulises Lara-Medina, Wendy R. Muñoz-Montaño, Juan W. Zinser-Sierra, Paula Anel Cabrera Galeana, Cynthia Villarreal Garza, Daniel Sanchez Benitez, Jesús Alberto Limón Rodríguez, Claudia Haydee Arce Salinas, Alberto Guijosa, Oscar Arrieta
Publikováno v:
Current Oncology, Vol 30, Iss 7, Pp 6097-6110 (2023)
(1) Background: recent evidence suggests that long low-dose capecitabine regimens have a synergistic effect with endocrine therapy as aromatase inhibitors (AIs), and might increase overall survival for hormone-receptor-positive, HER2-negative, metast
Externí odkaz:
https://doaj.org/article/41144420c00440e4872eb79005101da1